CD8A and neoplasm: CD8+ T cells derived from CLL patient–derived CD8+ T cells that were pretreated with were cocultured with MEC-1 cells in the presence of anti-CD3, which coats Fc receptors on tumor cells to facilitate TCR cross-linking.